• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Group incentives promote employee weight loss

bys25qthea
April 6, 2013
in Chronic Disease, Public Health
Reading Time: 2 mins read
Group incentives promote employee weight loss
Share on FacebookShare on Twitter

Image: PD/CDC

1. Obese employees randomized to group incentives lost more weight over a six-month period than those randomized to individual incentives or no incentives. 

2. Three months after the intervention ended, group-incentive participants maintained greater weight loss than no incentive participants.   

Study Rundown: During the six-month intervention, obese employees randomized to a group-incentivized weight loss program lost more weight than those offered individual incentives or no incentives and maintained a greater weight loss than those randomized to no incentives even three months after the intervention ended. This study’s overall generalizability may be limited because of a heavily female (89%), white (63%), and educated (92% attended at least some college) sample that was drawn from a single employer. Strengths of this investigation included withholding identities of the group-incentive participants from one another to minimize within-group behavior modification and adjusting monthly weight-loss goals to maximize participant retention. Follow-up studies in other populations and with longer-term follow-up would help contextualize intervention effectiveness.

Click to read the study in Annals of Internal Medicine

Click to read an accompanying editorial in Annals of Internal Medicine

RELATED REPORTS

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

In Depth: This [randomized controlled] trial assessed the effect of workplace-based, financially incentivized weight loss interventions on 105 obese (body mass index (BMI): 30-40) adult hospital employees. Participants were randomized by sex, age, and BMI into one of three groups (n=35 for each): no incentives (control group), individual incentives ($100 awarded if participants met monthly weight-loss goals), and group incentives ($500 split monthly between a 5-person subgroup if they met monthly weight-loss goals). Weight loss was assessed monthly during the six-month intervention and again at 9 months; changes in physical activity, eating behaviors, and weight-related wellness program participation were also recorded.

At six months, group-incentive participants had lost more weight than individual-incentive (mean difference: 3.2 kg, p=0.008) and no-incentive participants (mean difference: 4.4 kg, p<0.001). When reassessed 3 months after incentives ended, group-incentive participants maintained greater weight loss compared to no-incentive participants but not compared to individual-incentive participants.

By Caroline Huang and Leah Hawkins

More from this author: Varenicline reduces post-quit smoking relapses, Severe maternal childhood abuse associated with autism in offspring

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: group incentiveweight loss
Previous Post

Internal monitors associated with fever in laboring mothers

Next Post

Black men less likely to receive follow-up for elevated prostate cancer marker, PSA

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

July 9, 2026
Imaging and Intervention

Ring-augmented one-anastomosis gastric bypass may not improve weight loss compared to conventional one-anastomosis gastric bypass

June 10, 2026
Next Post
Black men less likely to receive follow-up for elevated prostate cancer marker, PSA

Black men less likely to receive follow-up for elevated prostate cancer marker, PSA

Classics Series, Landmark Trials in Medicine

The RE-LY trial: Dabigatran non-inferior to warfarin in preventing strokes in patients with atrial fibrillation [Classics Series]

Classics Series, Landmark Trials in Medicine

The AFFIRM trial: Rate-control vs. rhythm-control in atrial fibrillation [Classics Series]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.